Biogen C.E.O. to Step Down Following Launch of Alzheimer’s Drug, Aduhelm
The drug company will effectively give up on marketing Aduhelm, [...]
The drug company will effectively give up on marketing Aduhelm, [...]
The narrow 50-46 decision underscored the divisions on both sides [...]
Dr. Robert Califf, a former agency commissioner, is encountering opposition [...]
A Senate panel hearing on Tuesday signaled that Dr. Robert [...]
The 135-year-old company announced plans to divide itself into a [...]
Dr. Robert M. Califf, an academic and clinical trial researcher [...]